Dr. Craddock studies various health conditions, particularly migraines in children and adolescents, cochlear implants for individuals with hearing loss, and cancer diagnostics including lung cancer and appendiceal mucinous neoplasms. His research aims to uncover how environmental factors, biological changes, and innovative treatments impact patient well-being. For instance, he investigates how weather patterns might influence migraine attacks, evaluates the effectiveness of remote care for cochlear implant patients, and develops new diagnostic tools for precise cancer treatment.
Key findings
In a study of children and adolescents with migraines, there was no significant link found between Chinook winds and migraine attacks, with only 12% of observed days correlating with attack onset.
A randomised controlled trial indicated that remote care for cochlear implant patients is as effective as in-clinic visits, which can save time and money.
Research into brain chemicals during migraines showed that GABA increases prior to a migraine, while glutamate levels drop afterward, providing insights for better treatment options.
The implementation of CancelRx improved communication about prescription discontinuations, achieving a 93% success rate in stopping unnecessary medications, up from 34%.
The Comprehensive and Computable Molecular Diagnostic Panel (C2Dx) for lung cancer accurately classified tumor types from small tissue samples in 96% of cases, aiding personalized treatment decisions.
Frequently asked questions
Does Dr. Craddock study migraines?
Yes, he researches migraines specifically in children and adolescents to improve understanding and management of this condition.
What treatments has Dr. Craddock researched for hearing loss?
He has conducted studies on cochlear implants, particularly their effectiveness compared to traditional hearing aids.
Is Dr. Craddock's work relevant to patients with lung cancer?
Absolutely, his research includes developing diagnostic tools for lung cancer, which helps tailor treatments to individual patients.
How does Dr. Craddock's work affect cancer treatment?
His studies provide insights into tumor biology and improve diagnostic methods, leading to better-targeted therapies for cancer patients.
What advancements in prescription management has Dr. Craddock contributed to?
He developed tools like CancelRx to enhance communication regarding medication cancellations, which improves patient safety.
Publications in plain English
Chinook winds and migraine attack onset in children and adolescents: A prospective longitudinal clinical cohort study.
Plain English This study looked at whether dry and warm Chinook winds affect the onset of migraines in children and teens aged 8 to 18 in Southern Alberta, Canada. Researchers tracked 60 participants over several months and recorded migraine occurrences alongside changes in weather. They found no significant link between Chinook winds and migraine attacks, as only 12% of the days experienced were attack onset days, and stats didn’t show any clear patterns.
Who this helps: This information is important for patients dealing with migraines, as it clarifies that Chinook winds are unlikely to be a trigger for their headaches.
Randomised controlled trial to assess the efficiency and effectiveness of remote care compared with in-clinic care for adult cochlear implant recipients in the first 12 months after activation: a protocol of the INSPIRE study.
2025
BMJ open
Quaranta N, Murri A, Denys S, Verhaert N, Huinck W +11 more
Plain English The INSPIRE study looked at how effective remote care is for adults with cochlear implants during their first year after receiving the device, compared to traditional in-clinic visits. Researchers found that using an online system for check-ins and assessments can be just as effective as in-person visits for maintaining hearing ability, while also saving time and money for both patients and clinics. This matters because it can make post-surgical care easier and more accessible for many people, especially those living far from clinics.
Who this helps: This helps cochlear implant recipients, particularly those who struggle to travel for in-person care.
Region-specific changes in brain glutamate and gamma-aminobutyric acid across the migraine attack in children and adolescents.
2024
Pain
Cho LY, Bell TK, Craddock L, Godfrey KJ, Hershey AD +5 more
Plain English This study looked at the levels of two important brain chemicals, glutamate and GABA, in children and teenagers with migraines. Researchers found that before a migraine starts, GABA increases in the sensorimotor area of the brain, while glutamate levels drop in other areas like the occipital cortex and thalamus after the headache begins. Understanding these changes is important because they can help us develop better treatments for migraines in young people.
Who this helps: This research benefits children and adolescents with migraines and their doctors.
Single-cell sequencing reveals the landscape of the human brain metastatic microenvironment.
2023
Communications biology
Song Q, Ruiz J, Xing F, Lo HW, Craddock L +7 more
Plain English This study focused on understanding how various cells interact in the microenvironment of brain tumors that originate from other cancers, particularly breast and lung cancers. Researchers analyzed nearly 11,000 cells from brain tumor samples and found different types of cells, including those that create a supportive tissue framework and those that actively respond to tumors. They discovered that specific cells, called tumor-associated fibroblasts, play a major role in modifying the tumor environment, which may influence patient survival.
Who this helps: This research benefits doctors and researchers working on improved treatments for patients with brain metastases.
Impact of CancelRx on discontinuation of controlled substance prescriptions: an interrupted time series analysis.
2022
BMC medical informatics and decision making
Watterson TL, Stone JA, Gilson A, Brown R, Xiong KZ +8 more
Plain English This study looked at how well a new technology called CancelRx worked to inform pharmacies when patients' prescriptions for controlled substances, like opioids, were discontinued by their clinics. After CancelRx was put in place, there was a big increase of 77.7 percentage points in the successful communication of discontinuations to pharmacies, and this improvement was maintained over the following year. This matters because it helps ensure that patients aren’t given medications they no longer need, potentially reducing misuse and improving patient safety.
Who this helps: This benefits patients and doctors by improving prescription management and safety.
Skin flap thickness and magnet strength in Cochlear implants.
2021
Cochlear implants international
Searle T, Marshall E, Craddock L, Monksfield P
Plain English This study looked at how the thickness of skin affects the strength of magnets used in cochlear implants, specifically the new CI600 series, in 46 patients. Researchers found that patients with higher body mass indexes (BMIs) generally had thicker skin, which was significantly related to the need for stronger magnets. Since the CI600 has a lower magnet strength, thicker-skinned patients might face issues keeping the implant secure, leading to the possibility of needing surgery to reduce skin thickness.
Who this helps: This information benefits patients with cochlear implants, especially those who are overweight or have thicker skin.
CancelRx: a health IT tool to reduce medication discrepancies in the outpatient setting.
2021
Journal of the American Medical Informatics Association : JAMIA
Watterson TL, Stone JA, Brown R, Xiong KZ, Schiefelbein A +7 more
Plain English The study looked at a tool called CancelRx, which helps clinics communicate medication cancellations directly to pharmacies to prevent errors. After implementing CancelRx, the success rate of stopping medications jumped from 34% to 93%, and the time it took for these changes to be reflected in pharmacies was significantly reduced. This is important because it helps ensure patients are not taking medications they no longer need, which can improve their safety and health outcomes.
Who this helps: Patients who are prescribed medications.
Comprehensive and Computable Molecular Diagnostic Panel (C2Dx) From Small Volume Specimens for Precision Oncology: Molecular Subtyping of Non-Small Cell Lung Cancer From Fine Needle Aspirates.
2021
Frontiers in oncology
Su J, Huang LS, Barnard R, Parks G, Cappellari J +11 more
Plain English Researchers developed a new diagnostic tool called the Comprehensive and Computable Molecular Diagnostic Panel (C2Dx) that analyzes small tissue samples from lung cancer patients. The tool accurately classifies different types of Non-Small Cell Lung Cancer (NSCLC) using tiny amounts of tumor material, making it extremely useful. This matters because it provides a reliable way for doctors to tailor treatments specifically to the cancer type, potentially improving patient outcomes.
Who this helps: Doctors and lung cancer patients.
Prognostic Molecular Classification of Appendiceal Mucinous Neoplasms Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
2020
Annals of surgical oncology
Su J, Jin G, Votanopoulos KI, Craddock L, Shen P +6 more
Plain English This study looked at a rare but serious type of cancer called appendiceal mucinous neoplasm (AMN) that has spread to the abdomen. Researchers analyzed tumor samples from 138 patients who received specific surgeries and treatments and identified three distinct subtypes of AMN based on gene expressions. They found that patients with the immune-enriched subtype had better survival rates after treatment compared to those with the oncogene-enriched subtype, suggesting that the immune system plays a bigger role in fighting this cancer than previously thought.
Who this helps: This benefits patients with appendiceal mucinous neoplasm by helping doctors predict treatment outcomes.
Feasibility of lung cancer RNA acquisition from a single transbronchial or transthoracic needle pass (FASTT trial).
2019
Lung cancer (Amsterdam, Netherlands)
Dotson T, Bellinger C, Su J, Hansen K, Parks GE +11 more
Plain English This study looked at whether a small amount of lung cancer tissue collected from a single needle insertion during a biopsy could yield enough quality RNA for gene analysis. Researchers worked with 140 patients and found that 96% of the samples collected had sufficient RNA for testing, showing consistent results when compared to larger data sets. This is important because it means that even small tissue samples can provide valuable information for understanding different types of lung cancer and tailoring treatment accordingly.
Who this helps: Patients with lung cancer.
Dissecting intratumoral myeloid cell plasticity by single cell RNA-seq.
2019
Cancer medicine
Song Q, Hawkins GA, Wudel L, Chou PC, Forbes E +15 more
Plain English In this study, researchers examined how certain immune cells called myeloid cells change inside tumors from patients with early-stage non-small cell lung cancer (NSCLC). They analyzed nearly 11,500 cells and found that myeloid cells showed significant changes in their characteristics when comparing tumor tissue to normal tissue. Specifically, they discovered a consistent pathway where monocytes convert to a type of cell called M2 macrophages, which can promote tumor growth, while certain genes linked to inflammation decreased.
Who this helps: This research benefits patients with lung cancer and doctors treating them by improving our understanding of how tumors manipulate immune cells.
Cochlear implants for pre-lingually profoundly deaf adults.
2016
Cochlear implants international
Craddock L, Cooper H, Riley A, Wright T
Plain English This study looked at the experiences of 20 adults who were profoundly deaf since before they learned to speak and received cochlear implants. The findings showed that while the average group did not have significant improvements in understanding speech on their own, 12 of the patients benefited enough to use their implants for over 10 hours a day, which linked to better performance in understanding sentences when combining sound and lip-reading. These results highlight that cochlear implants can be helpful for adults who were born profoundly deaf, allowing them to communicate better.
Who this helps: Patients who are profoundly deaf and seeking cochlear implants.
Comparison of the benefits of cochlear implantation versus contra-lateral routing of signal hearing aids in adult patients with single-sided deafness: study protocol for a prospective within-subject longitudinal trial.
2014
BMC ear, nose, and throat disorders
Kitterick PT, O'Donoghue GM, Edmondson-Jones M, Marshall A, Jeffs E +9 more
Plain English This study looked at how well cochlear implants work compared to traditional hearing aids for adults with hearing loss in one ear. Researchers found that cochlear implants can improve the ability to hear sounds from different directions and understand speech in noisy environments, which is crucial for everyday listening. This matters because many people with single-sided deafness struggle in social settings, and cochlear implants might offer a better solution than the current standard aid.
Who this helps: This helps patients with single-sided deafness.
Journal for specialists in pediatric nursing : JSPN
Craddock L, Ray LD
Plain English This research focused on teaching families how to manage migraines in children effectively. It found that combining personalized behavioral strategies, lifestyle changes, and proper timing of medications can significantly reduce migraine pain and frequency. Educating families on triggers, setting goals, and understanding treatment options is crucial for better management of pediatric migraines.
Who this helps: This benefits children suffering from migraines and their families.
Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription.
2011
International journal of biological sciences
Yap F, Craddock L, Yang J
Plain English This study looked at how a protein called AMPK affects the production of SREBP-1c, which is important for making fats in the liver. The researchers found that when AMPK is activated, it can reduce the activity of SREBP-1c promoter by about 75%, even when a synthetic compound that typically boosts this activity is present. This is significant because understanding this process could help manage conditions related to fat buildup in the liver, such as fatty liver disease.
Who this helps: This research benefits patients with liver conditions, doctors treating metabolic disorders, and anyone at risk for fatty liver disease.
AMP-activated protein kinase suppresses LXR-dependent sterol regulatory element-binding protein-1c transcription in rat hepatoma McA-RH7777 cells.
2009
Journal of cellular biochemistry
Yang J, Craddock L, Hong S, Liu ZM
Plain English This study looked at how a protein called AMPK affects fat production in liver cells. Researchers found that when AMPK is activated by substances like AICAR and metformin, it significantly reduces the levels of SREBP-1c, a key protein involved in making fats, in liver cells. Specifically, AMPK reduced SREBP-1c mRNA by blocking its production and processing, which is important because excess fat in the liver can lead to health problems.
Who this helps: This benefits patients with fatty liver disease and those managing conditions like diabetes.
Chronic activation of AMP-activated protein kinase-alpha1 in liver leads to decreased adiposity in mice.
2008
Biochemical and biophysical research communications
Yang J, Maika S, Craddock L, King JA, Liu ZM
Plain English Researchers studied how long-term activation of a protein called AMPK-alpha1 in the liver affects fat levels in mice. They found that mice with this activation had significantly less white fat and were able to resist gaining weight even on a high-fat diet. This is important because it shows a potential way to reduce obesity and related health problems.
Who this helps: This helps patients at risk of obesity and related metabolic disorders.
The combination of raltitrexed (Tomudex) and mitomycin-C in the treatment of advanced colorectal cancer--a phase II study.
2006
Clinical oncology (Royal College of Radiologists (Great Britain))
Michels J, Geldart T, Darby A, Craddock L, Iveson A +2 more
Plain English This study looked at using a combination of two drugs, raltitrexed and mitomycin-C, to treat patients with advanced colorectal cancer. Out of 22 patients, 20% showed signs of improvement, while 40% had stable disease. However, the study was stopped early due to safety concerns, including three unexpected deaths linked to the treatment. The average time before the cancer worsened was just under 4 months, and patients lived about 11.6 months on average after starting the treatment. Because of the serious risks involved, this combination is not recommended as a first treatment option for advanced colorectal cancer.
Who this helps: This research helps doctors understand the risks of this drug combination for their patients.
Normative findings of electrically evoked compound action potential measurements using the neural response telemetry of the Nucleus CI24M cochlear implant system.
2005
Audiology & neuro-otology
Cafarelli Dees D, Dillier N, Lai WK, von Wallenberg E, van Dijk B +28 more
Plain English This study looked at how the Nucleus 24 cochlear implant system performs in adults from 13 European countries by measuring the electrical responses in their auditory nerves after the implant was activated. They found that 96% of the 147 subjects could be successfully tested, resulting in established normal ranges for key measurements like peak amplitude and response time, with younger patients (ages 15-30) showing higher response amplitudes. This research helps improve how doctors assess cochlear implant function and tailor treatment based on patient age and response patterns.
Who this helps: Patients with cochlear implants and their doctors.
Evaluation of bilaterally implanted adult subjects with the nucleus 24 cochlear implant system.
2005
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
Ramsden R, Greenham P, O'Driscoll M, Mawman D, Proops D +11 more
Plain English This study looked at the benefits of getting a second cochlear implant for adults who already had one. Researchers tested 30 participants, aged 29 to 82, and found that listening in noise was worse in the second ear by about 14%. However, having two implants provided a significant advantage for hearing in noise, improving speech understanding by around 12.6% when sound came from the front and 21% when the noise was in the same ear as the first implant. This research shows that getting a second cochlear implant can greatly enhance hearing capabilities for users.
Who this helps: This benefits adults with hearing loss who are considering a second cochlear implant.
Comparison between NRT-based MAPs and behaviourally measured MAPs at different stimulation rates--a multicentre investigation.
2003
Cochlear implants international
Craddock L, Cooper H, van de Heyning P, Vermeire K, Davies M +8 more
Plain English This study looked at two different ways to set hearing device settings (MAPs) for adults: one using a new technique called NRT and the other based on their actual behavior. They found that while there were some differences in the predicted performance levels between the two methods, the tests for understanding speech showed that both methods worked equally well. This matters because it helps determine the best ways to adjust hearing devices to ensure patients can hear clearly and understand speech effectively.
Who this helps: Patients with hearing loss.
Pilot study of intravenous magnesium sulfate in refractory cardiac arrest: safety data and recommendations for future studies.
1995
Resuscitation
Miller B, Craddock L, Hoffenberg S, Heinz S, Lefkowitz D +4 more
Plain English This study looked at how intravenous magnesium sulfate (MgSO4) affects patients who have cardiac arrest that doesn’t respond to standard resuscitation efforts. Out of 29 patients given MgSO4, 35% showed some signs of recovery, compared to 21% in the standard treatment group, though these results weren't statistically significant. Importantly, while MgSO4 did not significantly harm patient outcomes, a majority of those treated with it experienced low blood pressure after regaining heart function, which is something that needs careful monitoring.
Who this helps: This research benefits doctors and emergency responders dealing with patients in cardiac arrest.
Resuscitation from prolonged cardiac arrest with high-dose intravenous magnesium sulfate.
1991
The Journal of emergency medicine
Craddock L, Miller B, Clifton G, Krumbach B, Pluss W
Plain English This study looked at a patient who experienced a prolonged cardiac arrest lasting 70 minutes during surgery, which did not respond to standard treatments. After giving 8 grams of magnesium sulfate, the patient’s heart rhythm stabilized and returned to normal within 4 minutes. This finding is important because it shows that magnesium sulfate can be effective in restarting the heart after such a critical situation, potentially saving lives.
Who this helps: This benefits patients experiencing cardiac arrest and the medical teams treating them.